BSE filing, NSE: VAKRANGEE. Summary written from the filing by ALFA Finder's alert engine.
Vakrangee Ltd: key numbers
- Share price
- ₹5.79
- Market cap
- ₹627.4 Cr
- Revenue (annual)
- ₹254.8 Cr
- Net profit (annual)
- ₹11.27 Cr
- P/E (TTM)
- 57.8×Sector 43.1×
- Promoter holding
- 40.04%-0.01% QoQ
- FII holding
- 0.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vakrangee Ltd
All →Vakrangee Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹6,408.9L (+10.7% QoQ), EBITDA ₹945.9L (15.3% margin), PAT ₹272.8L (+20.9% QoQ). Debt-free; quarterly GTV ₹12,976.8 Cr.
Vakrangee Results Update
Vakrangee reported Q2 FY27 PAT of ₹272.8 Lakh, up 20.9% QoQ, on 10.7% revenue growth. GTV reached ₹12,976 crore across 23,885 outlets.
Vakrangee Q2 FY27 Results: Net Profit ₹2.7 Cr, Down 10.0% YoY
Vakrangee Ltd reported revenue from operations of ₹61.7 Cr (-10.7% YoY) and net profit of ₹2.7 Cr (-10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr · -10.0% YoY
Vakrangee Board Meeting Date
Vakrangee Limited has notified a board meeting on 28 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is an advance notice; the meeting has not yet been held.
Vakrangee Other Announcement
Vakrangee Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Vakrangee Annual General Meeting
Vakrangee shareholders passed six resolutions at its 36th AGM, including MD re-appointment and MOA alteration. The meeting was held via video conference on September 23, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date